Ledger.Open graph →

SEC Form D · Amendment · filed October 30, 2009

XANODYNE PHARMACEUTICALS INC

Offering

$87.8M

Sold

$87.8M

Exemption

—

Industry

Pharmaceuticals

Location

NEWPORT, KY

Type

—

People & firms on this filing (30)

Dennis Purcell · Newport, KYDirector Rita M. O'Connor · Newport, KYExec Natasha Giordano · Newport, KYExec Rolf A. Classon · Newport, KYDirector Thomas P. Jennings · Newport, KYExec Gary A. Shangold · Newport, KYExec Daniel W. Docherty · Newport, KYExec Vaughn M. Kailian · Newport, KYDirector Steven St. Peter · Newport, KYDirector James Shannon · Newport, KYDirector Peter Wentworth · Newport, KYExec Michael Valentino · Newport, KYExec · Director Kevin T. Anderson · Newport, KYExec Craig Tooman · Newport, KYDirector Patrick Enright · Newport, KYDirector Ori Eyal · New York, NYDirector David Coker · Greenwood Village, COExec · Director Jody Seltzer · Littleton, CODirector Damien Waples · Roseville, CADirector Barlow Christopher · Mobile, ALDirector Billie Jo Nutter · Mobile, ALExec Thomas L. Greer · Atlanta, GAExec Thomas Dixon · Mobile, ALExec Jeff Greenblum · Houston, TXExec William J. Nelligan · FORT WORTH, TXDirector Karla L. Packer · FORT WORTH, TXDirector John R. Walsh · FORT WORTH, TXExec Kevin S. Mckay · FORT WORTH, TXExec Adel Al-Saleh · FORT WORTH, TXExec Patrick Enright · Reading, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗